105 Participants Needed

Mindfulness App Training for Heart Disease

(MATCH Trial)

TW
EK
Overseen ByEmily K Lindsay, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual care, as the study compares mindfulness training to regular routines.

What data supports the effectiveness of the treatment Mindfulness App Training for Heart Disease?

Research shows that online mindfulness training can lead to small improvements in exercise capacity, blood pressure, mental functioning, and depression in heart disease patients, suggesting it could be a helpful addition to usual care.12345

Is mindfulness training safe for humans?

Mindfulness training is generally considered safe for humans and is often used to improve psychological well-being and quality of life. It has been integrated into healthcare for self-care and disease management, with studies supporting its use in various conditions.34567

How does the Mindfulness App Training for Heart Disease treatment differ from other treatments?

This treatment is unique because it uses mindfulness training, which can help reduce stress and improve emotional regulation, potentially leading to better exercise capacity and mental health in heart disease patients. Unlike traditional treatments that focus on medication, this approach emphasizes self-care and stress management through mindfulness practices.12345

What is the purpose of this trial?

This study will investigate the feasibility and effects of a smartphone-based mindfulness training program vs. usual care in a sample of stressed midlife and older adults at risk for cardiovascular disease. 105 participants will be randomly assigned to complete a four-week mindfulness training intervention, which involves 28 audio-guided lessons and practice prompts delivered 3x daily, or to continue with their regular routines. Data will be collected at baseline, post-intervention, and three-month follow-up. The study will involve seven laboratory visits, which will include assessments and training on daily life monitoring and intervention procedures. Data assessing subjective and physiological stress reactivity in daily life will be collected for 3 days at pre-intervention, post-intervention, and 3-month follow-up. Passive sensor data will be continuously collected from participants' smartphones and wearable devices to develop models that predict daily life stress. Data will be used to evaluate feasibility of the intervention and assessments in a sample at risk for cardiovascular disease and to test effects of mindfulness training on subjective and physiological stress reactivity.

Research Team

TW

Thomas W Kamarck, PhD

Principal Investigator

University of Pittsburgh

EK

Emily K Lindsay, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

Adults aged 45+ in the Pittsburgh area with hypertension and moderate-to-high cardiovascular risk are eligible. They must have a compatible smartphone, speak English well, and be available for study visits. Excluded are those with severe heart conditions, night shift workers, heavy drinkers or drug users, pregnant women, individuals with certain mental health issues or who practice mind-body exercises regularly.

Inclusion Criteria

I am 45 years old or older.
Living in the Pittsburgh area for the next 5 months and available for study visits and activities during this period
High perceived stress (above 15 on the 10-item Perceived Stress Scale)
See 3 more

Exclusion Criteria

Pregnancy
Positive PTSD screen (traumatic event(s) endorsed and total score ≥3 on Primary Care PTSD screen for DSM-5)
Typical alcohol consumption ≥15 drinks per week
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a smartphone-based mindfulness training program or continue their regular routines for 4 weeks

4 weeks
7 laboratory visits for assessments and training

Post-Intervention Monitoring

Participants complete a second week of daily life monitoring, including assessments of stress reactivity and cardiovascular responses

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment, including a third week of monitoring three months later

3 months

Treatment Details

Interventions

  • Enhanced Usual Care
  • Mindfulness Training
Trial Overview The trial is testing if using a mindfulness app can help stressed adults at risk of heart disease. Half will use the app daily for four weeks; the other half won't change their routine. Stress levels will be measured before and after intervention and again three months later using lab visits and wearable devices.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness TrainingExperimental Treatment1 Intervention
Mindfulness intervention involving 28 audio-guided lessons plus daily brief practice prompts. Lessons train meditation techniques for 3 mindfulness skills: concentration, sensory clarity, and equanimity. Practice prompts delivered 3x daily build on the skills trained in each lesson.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Participants in the EUC condition will have no study requirements during the 4-week intervention period, but they will receive a list of stress management resources upon randomization (websites, books, health tracking apps, and mental health services) with no additional intervention support.

Enhanced Usual Care is already approved in United States, European Union, China for the following indications:

🇺🇸
Approved in United States as Lactulose for:
  • Hepatic encephalopathy
  • Constipation
🇪🇺
Approved in European Union as Lactulose for:
  • Hepatic encephalopathy
  • Constipation
🇨🇳
Approved in China as Lactulose for:
  • Hepatic encephalopathy
  • Constipation

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

In a study involving 324 patients with heart disease, 12 weeks of online mindfulness training resulted in a borderline significant improvement in exercise capacity, as measured by the 6-minute walk test, compared to usual care alone.
Mindfulness training also significantly reduced heart rate in patients, suggesting it may be a beneficial addition to standard treatments for improving physiological health in heart disease patients.
Web-Based Mindfulness Intervention in Heart Disease: A Randomized Controlled Trial.Younge, JO., Wery, MF., Gotink, RA., et al.[2018]
A 12-month follow-up study involving 324 patients with heart disease showed that online mindfulness training led to a small but significant improvement in exercise capacity, with participants walking an average of 17.9 meters further in a 6-minute test compared to usual care.
Mindfulness training also resulted in favorable long-term effects on systolic blood pressure, mental functioning, and depressive symptoms, suggesting it could be a beneficial addition to standard clinical care for heart disease patients.
Online mindfulness as a promising method to improve exercise capacity in heart disease: 12-month follow-up of a randomized controlled trial.Gotink, RA., Younge, JO., Wery, MF., et al.[2019]
Mindfulness training for primary care (MTPC) significantly improved emotion regulation in patients with anxiety, depression, and stress-related disorders, showing reductions in difficulties in emotion regulation scores at both 8 and 24 weeks compared to a low-dose mindfulness comparator.
MTPC also facilitated health behavior change, with 63% of participants successfully initiating their action plans within 3 weeks, compared to only 38% in the low-dose group, indicating its effectiveness in promoting self-management of chronic illnesses.
Impact of warm mindfulness on emotion regulation: A randomized controlled effectiveness trial.Gawande, R., Smith, L., Comeau, A., et al.[2023]

References

Web-Based Mindfulness Intervention in Heart Disease: A Randomized Controlled Trial. [2018]
Online mindfulness as a promising method to improve exercise capacity in heart disease: 12-month follow-up of a randomized controlled trial. [2019]
Impact of warm mindfulness on emotion regulation: A randomized controlled effectiveness trial. [2023]
Mindfulness and physical disease: a concise review. [2020]
Mind Your Heart: Exploring Feasibility, Acceptability, and Preliminary Effects of Phone-Delivered Mindfulness Training on Medication Adherence in Outpatients With Chronic Heart Failure. [2023]
The effect of a brief mindfulness-based stress reduction program on strengthening awareness of medical errors and risks among nursing students. [2023]
A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security